Artificial Intelligence, Part 1: Bias, Access, ROI, Potential Success and Failure

This is part one of a discussion focused upon data bias, accuracy, access and the future of AI in drug development. Topics explored are ROI, human bias, data challenges, data management plans, and human expertise.

Host 
Lori Ellis, Head of Insights, BioSpace 
 
Guests 
Paul Agapow, Director of Innovation, Data Science and Strategy, GlaxoSmithKline
Mike King, Senior Director of Product and Strategy, IQVIA 
Nindhana Paranthaman, Executive Medical Director, Exelixis 
Moritz von Stosch, Chief Information Officer, DataHow